SELLAS Life Sciences Group, Inc. SLS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s EPS (diluted)?
- SELLAS Life Sciences Group, Inc. (SLS) reported EPS (diluted) of -$0.05 in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s EPS (diluted) changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s EPS (diluted) increased by 28.6% year-over-year, from -$0.07 to -$0.05.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s EPS (diluted) has grown at a -34.2% compound annual growth rate (CAGR), from -$1.33 to -$0.25.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.